CClinicalTrials.gg
CompletedNCT05955690Updated Jul 20, 2025

Knowledge and Attitude of Pregnant Women Towards Preeclampsia in Assiut Governorate

An observational study in Preeclampsia, sponsored by Assiut University. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-07-20.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
261
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Our study will be a cross sectional study to evaluate the knowledge level and attitude of pregnant women towards preeclampsia and factors affecting it ,the study will be done at Assiut University Hospitals - Women's Health Hospital. all pregnant women who will come to ANC visits will be included .the study tool is a well structured questionnaire for assessment of our outcomes.

Read the detailed description

Preeclampsia is a pregnancy-related hypertensive disorder that usually occurs after 20 weeks of gestation. It is characterised by hypertension and proteinuria . Preeclampsia is the leading cause of maternal death, complicating about one-tenth of all pregnancies worldwide . It is the second greatest cause of direct maternal death, accounting for 70,000 maternal mortality globally each year .The burden of preeclampsia and eclampsia is most significant in low- and middle-income countries (LMICs), where hypertensive disorders of pregnancy account for 10-15% of maternal deaths.

Early detection of symptoms, rapid presentation to healthcare facilities, and subsequent management with antihypertensive medications, magnesium sulphate, and delivery of the foetus and placenta improve outcomes in pregnancies complicated by preeclampsia and eclampsia . As a result, ANC visits and intrapartum admission are critical chances for patient counselling Despite the essential relationship between women's awareness of preeclampsia and health seeking behaviour, research on this topic is limited, particularly in underdeveloped countries. Even in developed countries, studies in high-income countries show that only half of patients were counselled about preeclampsia signs and symptoms, despite the fact that counselling by healthcare personnel is related to higher patient knowledge. So there is a gap in studying pregnant women's knowledge and attitudes concerning preeclampsia in underdeveloped countries, particularly Egypt, where studies on this topic are scarce.

02

Conditions studied

  • Preeclampsia

Browse trials for

03

In context

Pre-Eclampsia

882 studies on the registry are indexed under Pre-Eclampsia; 237 are open to participants now.

This study's enrollment of 261 is above the median of 163 across 380 observational studies indexed under Pre-Eclampsia.

Browse Pre-Eclampsia studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All pregnant women in first, second and third trimester who will come to receive antenatal care (ANC) services

Inclusion criteria

  • All pregnant women.
  • pregnant women in first, second and third trimester.
  • pregnant women who come to receive ANC at Assiut University Hospitals - Women's Health Hospital out patient clinic.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women that are unwell to give consent.
  • Pregnant women who are already diagnosed by preeclampsia and eclampsia.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
261 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Prevalence of Knowledge of pregnant women about preeclampsia

    assessement of knowledge"poor,moderate or good " by answering a structured questionnaire .The women will answer by yes , no or I don't know , A scoring system, where a correct answer attracts a score of one (1) and a wrong or no response (or I don't know) attracts a score of zero (0) was used to scale participants' knowledge of preeclampsia . The scores were expressed as percentages and Bloom's cut-off point will be employed to classify knowledge of PE into three levels: poor (\< 60%), moderate (60-80%) and good (80-100%).high score means a better outcome .

    Time frame: just after ending the interview in which we filled in questionnaire

  2. Attitude of pregnant women towards preeclampsia

    assessement of attitude ""positive ,neutral or negative " by answering a structured questionnaire.The women will answer by agree ,disagree or unsure , Attitude was reported as positive, neutral and negative when they scored 80-100 %, 60-79 %, and less than 60 % of the attitude assessment questions respectively using the Bloom's cut-off point.

    Time frame: just t after ending the interview in which we filled in questionnaire

  3. Associated factor with knowledge and attitude of pregnant women towards preeclampsia

    studying sociodemographic ,medical and obstetric factors that affect knowledge and attitude of pregnant women towards preeclampsia by well structured questionnaire "by the previous scale"

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Assiut university
    Asyut, 71515, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05955690
Lead sponsor
Assiut University
Responsible party
Gehad Khalaf Refaey (Principle investigator, Assiut University) — Principal investigator
First posted
Jul 21, 2023
Start date
Jan 1, 2024
Primary completion
Dec 1, 2024
Completion
Jun 1, 2025
Last update
Jul 20, 2025

Study contacts

Ahmed M Abbas, MD
study chair · Assiut University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion